cpg-odn
Nucleic acidexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2021 (NCT04952272)
Timeline
2020s
- Jan 1, 2021
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06047015 | Phase 1/Phase 2 (Phase 2) | Jan 31, 2024 | University of Saskatchewan |
| NCT04952272 | Phase 1 | Mar 1, 2021 | Guangdong Zhaotai InVivo Biomedicine Co. Ltd., Guangzhou Medical University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Guangdong Zhaotai InVivo Biomedicine Co. Ltd. | Government | 1 | 0 | 1 | 2021 |
| Guangzhou Medical University | Academic/Hospital | 1 | 1 | 1 | 2021 |
| University of Saskatchewan | Academic/Hospital | 1 | 1 | 1 | 2024 |
3 organizations
Page 1 / 1